Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | arginase, putative | 0.1856 | 0.5 | 0.5 |
Schistosoma mansoni | arginase | 0.1856 | 0.5 | 0.5 |
Leishmania major | arginase | 0.1856 | 0.5 | 0.5 |
Trichomonas vaginalis | Arginase, putative | 0.1856 | 0.5 | 0.5 |
Echinococcus multilocularis | arginase 2, mitochondrial | 0.1856 | 0.5 | 0.5 |
Entamoeba histolytica | Arginase, putative | 0.1856 | 0.5 | 0.5 |
Echinococcus multilocularis | 0.1856 | 0.5 | 0.5 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.1856 | 0.5 | 0.5 |
Plasmodium falciparum | arginase | 0.1856 | 0.5 | 0.5 |
Echinococcus granulosus | arginase 2 mitochondrial | 0.1856 | 0.5 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1856 | 0.5 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.